Skip to content

Author

O. Abiodun

We have 6 of 44 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Global, Regional, and National Burden of Myocarditis and Its Impairment, 1990-2023.

BACKGROUND The impact of recent trends in the burden of myocarditis has not been reported in detail. OBJECTIVES This study aims to estimate the global, regional, and national burden of myocarditis from 1990 to 2023, using data from the GBD (Global Burden of Disease, Injuries, and Risk Factors Study) 2023. METHODS A...

Sooji Lee, Hayeon Lee, Min Seo Kim et al. · 0 citations
Review Open access Sep 2026

Global, regional, and national burden of exposure to chewing tobacco, 1990-2023: a systematic analysis of the Global Burden of Disease Study 2023.

BACKGROUND Exposure to chewing tobacco is a known health risk factor but has received less attention than smoking in global tobacco control efforts. As the evidence base linking chewing tobacco use to poor health grows, it is essential to closely track the changing use of chewing tobacco distinct from other forms of sm...

G. Gil, Jason A. Anderson, Xiao-Chen Dai et al. · 1 citation
Review Open access Sep 2026

Burden of non-communicable diseases and their attributable risk factors in Africa from 1990 to 2023: a systematic analysis for the Global Burden of Disease Study 2023.

BACKGROUND The rapid rise in the burden of non-communicable disease (NCDs) in African communities has resulted in a considerable mortality, disability, and economic burden. A comprehensive evaluation of incidence, deaths, disability-adjusted life-years (DALYs), and attributable risk factors related to NCDs by sex, and...

A. Awedew, Mihretu Jegnie, K. Abate et al. · 0 citations
Review Open access Sep 2026

Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

It is estimated that SHS remains a substantial driver of global health loss, particularly through cardiovascular and paediatric respiratory diseases, and growing absolute numbers of exposed individuals in several regions underscore the urgent need for accelerated implementation and enforcement of comprehensive tobacco...

L. Flor, Jason A. Anderson, Brooks W. Morgan et al. · 0 citations
Open access Aug 2026

Association of 10-year Cardiovascular Risk with Left Ventricular Hypertrophy in a Population of Nigerian Hypertensives.

An elevated 10-year ASCVD risk was associated with a two-fold increase in the risk of echocardiographic and ECG LVH in a population of Nigerian hypertensives, suggesting the use of the ASCVD risk score may facilitate timely referrals for the diagnosis and management of LVH.

O. Abiodun, Tina Anya · 0 citations
Open access Jul 2026

Home blood pressure telemonitoring reveals race-specific patterns of target organ damage.

Intensifying pharmacological treatment in sub-Saharan Africa, including antihypertensives, lipid-lowering agents, antidiabetic medications, and aspirin, should create an opportunity for improved overall cardiovascular and metabolic prevention.

Dong-Yan Zhang, De-Wei An, Yu-Ling Yu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.